General
On August 22, 2024, the FDA approved and granted emergency use authorization (EUA) to the 2024-2025 formulation of both the Moderna COVID-19 and the Pfizer-BioNTech COVID-19 vaccines for everyone 6 months of age and older. On August 30, the FDA granted EUA to the updated 2024-2025Novavax COVID-19 vaccine. The updated COVID vaccines were also endorsed by the Advisory Committee on Immunization Practices (ACIP) and the CDC.
This is a list of provider cost list
Acute Flaccid Myelitis
Increase in Human Parvovirus B19 Activity in the United States
Proclamation - World Breastfeeding Week 2024
Cannabis Use During Pregnancy and While Nursing
Cannabis and Adolescents
NMHSC Stipend Reference Letter for 2024 - 2025
SoNM Substitute - W9 Form
Complete fee schedule for the scientific laboratory division's biological sciences bureau.
Complete fee schedule for the scientific laboratory division's chemistry bureau.
Confirmed Case of Acute Flaccid Myelitis (AFM)
Highly Pathogenic Influenza Testing Reminder
Two Cases of Measles Confirmed in Taos County
CNM Rule Changes as of 5-9-24
Xylazine Detected in NM Drug Supply
NMDOH Marks The End of The 2023 - 2024 Influenza Season
Healing Addiction in our Community Resources List